Biosyntia, Lantana Bio in botanical deal
French white biotech firm Lantana Bio and Danish biotech Biosyntia have signed an in-licensing deal for flavonoids.
Under this, they will jointly develop production processes for flavonoids for applications mainly in food but also personal care and other applications. Biosyntia will be responsible for bringing these processes into production and commercialising the ingredients.
Flavonoids are a group of actives that are present in several traditional Chinese medicine herbs with multiple claimed health benefits. The first to be developed is kaempferol, which will be the first fermented version on the world market.
“The jointly developed technology platform will deliver today’s commercial flavonoids in a sustainable and natural way, but over time it has the potential to deliver thousands of high-quality flavonoids not previously possible to produce,” Biosyntia said.
Other News
Featured Supplier
Natural Plant Products, Inc. has produced botanical oils/extracts for the personal care industry for over 30 years. Grown in the USA on cooperative member farms their natural products, Meadowfoam Seed Oil, Daikon Seed Extract, and Meadowfoam CP, have unique chemistries. These novel triglycerides offer long-term oxidative stability, providing...
Upcoming Events
Testing of Personal Care Formulations
Burlington House, London
Thursday 17th March 2022
in-cosmetics Global 2022 - Paris
1 Pl. de la Porte de Versailles, Paris
5 - 7 April 2022
NYSCC Suppliers' Day 2022
Javits Center, New York
3 - 4 May 2022
in-cosmetics Korea 2022
Hall C, Coex, Seoul, South Korea
13 - 15 July 2022
PCHi China 2022
Shanghai World Expo Exhibition & Convention Center
18 - 20 July 2022
32nd IFSCC Congress
Park Plaza Hotel, Westminster
19-22 September 2022
Access the latest issue of Personal Care Magazine on your mobile device together with an archive of back issues.
Download the FREE Personal Care Magazine app from your device's App store
